Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
8.31
+0.03 (0.36%)
At close: Jun 18, 2025, 4:00 PM
8.80
+0.49 (5.90%)
After-hours: Jun 18, 2025, 7:47 PM EDT
CRBP Stock Forecast
CRBP's stock price has decreased by -81.2% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 10 analysts that cover CRBP stock have a consensus rating of "Strong Buy" and an average price target of $53.56, which forecasts a 544.52% increase in the stock price over the next year. The lowest target is $35 and the highest is $75.
Price Target: $53.56 (+544.52%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 7, 2025.
Analyst Ratings
The average analyst rating for CRBP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
Buy | 5 | 6 | 6 | 6 | 6 | 6 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $65 → $58 | Buy | Maintains | $65 → $58 | +597.95% | May 7, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $60 → $56 | Buy | Maintains | $60 → $56 | +573.89% | May 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +381.35% | May 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 → $50 | Strong Buy | Reiterates | $75 → $50 | +501.68% | Mar 12, 2025 |
Jefferies | Jefferies | Strong Buy Maintains $70 → $53 | Strong Buy | Maintains | $70 → $53 | +537.79% | Mar 11, 2025 |
Financial Forecast
Revenue This Year
1.46M
Revenue Next Year
3.64M
from 1.46M
Increased by 150.03%
EPS This Year
-6.25
from -3.68
EPS Next Year
-5.33
from -6.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.5M | 26.3M | 26.3M | ||
Avg | 1.5M | 3.6M | 3.6M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 1,701.6% | 620.6% | ||
Avg | - | 150.0% | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -4.49 | -4.22 | -3.73 | ||
Avg | -6.25 | -5.33 | -6.48 | ||
Low | -12.31 | -6.38 | -8.48 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.